17
Apr
2024

Erregierre SpA

Exhibitor at CPHI Japan 2024 stand IP-21
About Us

Erregierre with its two production sites, one located in San Paolo D'Argon (Bergamo) and the other one located in Sovere (Bergamo), is a privately owned independent Italian company established in 1974. It is one of the leading manufacturer of pharmaceutical active ingredients produced by synthesis and exported worldwide. Erregierre has been FDA inspected and is strongly committed in manufacturing in strict accordance with cGMPs and at the highest international quality standards.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contact info
Event information
CPHI Japan 2024
  • 17 Apr 2024 – 19 Apr 2024
  • East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
  • Visit us at stand IP-21

Products Featured at CPHI Japan 2024

  • Acebutolol hydrochloride

    Product Acebutolol hydrochloride

    Erregierre SpA manufactures a wide range of API's which includes acebutolol hydrochloride. It belongs to ? adrenergic blocking agent and antihypertensive category. Contact us for more information.
  • Ambroxol hydrochloride

    Product Ambroxol hydrochloride

    Erregierre SpA manufactures a wide range of API's which includes ambroxol hydrochloride. It belongs to expectorant category. Contact us for more information.
  • Amisulpride

    Product Amisulpride

    Erregierre SpA manufactures a wide range of API's which includes amisulpride. It belongs to antipsychotic category. Contact us for more information.
  • Aripiprazole

    Product Aripiprazole

    Erregierre SpA manufactures a wide range of API's which includes aripiprazole. It belongs to antipsychotic category. It is a new product of the company. Contact us for more information.
  • Bifonazole

    Product Bifonazole

    Erregierre SpA manufactures a wide range of API's which includes bifonazole. It belongs to antifungal agents category. Contact us for more information.